Mirum Pharmaceuticals Inc (MIRM)
46.26
+2.34
(+5.33%)
USD |
NASDAQ |
Nov 14, 16:00
48.11
+1.85
(+4.00%)
After-Hours: 06:30
Mirum Pharmaceuticals Free Cash Flow: -39.22M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -39.22M |
| March 31, 2024 | -42.04M |
| December 31, 2023 | -91.05M |
| September 30, 2023 | -103.95M |
| June 30, 2023 | -111.77M |
| March 31, 2023 | -114.56M |
| December 31, 2022 | -120.41M |
| September 30, 2022 | -138.05M |
| June 30, 2022 | -146.23M |
| March 31, 2022 | -166.24M |
| Date | Value |
|---|---|
| December 31, 2021 | -151.78M |
| September 30, 2021 | -135.94M |
| June 30, 2021 | -119.22M |
| March 31, 2021 | -96.06M |
| December 31, 2020 | -89.30M |
| September 30, 2020 | -66.76M |
| June 30, 2020 | -64.65M |
| March 31, 2020 | -55.62M |
| December 31, 2019 | -39.64M |
Free Cash Flow Range, Past 5 Years
-166.24M
Minimum
Mar 2022
-39.22M
Maximum
Jun 2024
-99.61M
Average
-103.95M
Median
Sep 2023
Free Cash Flow Benchmarks
| Arcutis Biotherapeutics Inc | -167.80M |
| Cytokinetics Inc | -407.05M |
| Amicus Therapeutics Inc | -31.51M |
| MannKind Corp | 28.87M |
| TG Therapeutics Inc | -28.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.803M |
| Cash from Investing (Quarterly) | -72.72M |
| Cash from Financing (Quarterly) | 7.291M |
| Free Cash Flow Per Share (Quarterly) | -0.3087 |
| Free Cash Flow to Equity (Quarterly) | -14.99M |
| Free Cash Flow to Firm (Quarterly) | -14.50M |
| Free Cash Flow Yield | -1.86% |